Protalix BioTherapeutics (PLX) Q1 2025 Earnings

17MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.06
-0.01
0.05
0.1

Details

Expected EPS
0.07
Actual EPS
0.1
Surprise EPS
0.03
Surprise Percent
+42.86%

Description

Protalix BioTherapeutics (PLX) has reported earnings of 0.1 per share for Q1 2025.

0 Comments

Share your thoughts